Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2130.0000 (0%) ($1995.0000 - $2130.0000) on Sat. Sep. 27, 2008. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.48% (three month average) | | RSI | 16 | | Latest Price | $2130.0000(0%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | CAPR declines -3% a day on average for past five trading days. | | Weekly Trend | CAPR declines -5.2% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
(0%) (0%) (0%) (0%) (0%) | | Factors Impacting CAPR price | CAPR will decline at least -1.74% in a week (0% probabilities).
(0%) (0%) (0%) (0%) (0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.74% (StdDev 3.48%) | | Hourly BBV | 0 () | | Intraday Trend | 6.2% | | | | | |
|
| Resistance Level | $2407.44 | | 5 Day Moving Average | $2238(-4.83%) | | 10 Day Moving Average | $2355.46(-9.57%) | | 20 Day Moving Average | $2407.44(-11.52%) | | To recent high | -18.9% | | To recent low | 13% | | Market Cap | $N/A | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |